Insulin glargine
- Biologic
- Lantus Solostar
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Insulin glargine: storage and handling
- Refrigerate
- Yes, as the label states
Label statement
Store unused LANTUS in a refrigerator between 36°F and 46°F (2°C and 8°C).
- Freezing
- Do not freeze
Label statement
Do not freeze.
- Room temperature
- up to 28 days at or below 30°C (86°F)
Label statement
Not in-use (unopened) Not in-use (unopened) In-use (opened) Refrigerated Room Temperature (36°F–46°F [2°C–8°C]) (up to 86°F [30°C]) (see temperature below) 10 mL multiple-dose vial Until expiration date 28 days 28 days Refrigerated or room temperature 3 mL single-patient-use SoloStar prefilled pen Until expiration date 28 days 28 days Room temperature only (Do not refrigerate)
- Back into the refrigerator
- Not addressed
- Light
- Not addressed
- Shaking
- Not addressed
All storage statements on the label (5)
- Store unused LANTUS in a refrigerator between 36°F and 46°F (2°C and 8°C).
- Do not freeze.
- Discard LANTUS if it has been frozen.
- Protect LANTUS from direct heat and light.
- Not in-use (unopened) Not in-use (unopened) In-use (opened) Refrigerated Room Temperature (36°F–46°F [2°C–8°C]) (up to 86°F [30°C]) (see temperature below) 10 mL multiple-dose vial Until expiration date 28 days 28 days Refrigerated or room temperature 3 mL single-patient-use SoloStar prefilled pen Until expiration date 28 days 28 days Room temperature only (Do not refrigerate)
FDA label version 35, effective June 2, 2025. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Biosimilars
Lantus: 3 licensed biosimilar products, 3 interchangeable (FDA Purple Book). Compare presentations and dates
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.